SCHEMBL9260246

SCHEMBL9260246

O=C(O)COc1ccc(-c2nc3[nH]c(=O)[nH]c(=O)c3[nH]2)cc1

nearest known ligand 0.62

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 14/20 0.62
▸ ADORA3 P0DMS8 7/20 0.59
▸ ADORA2A P29274 7/20 0.57
▸ MEN1 O00255 1/20 0.54
▸ KMT2A Q03164 1/20 0.54
▸ ADORA1 P30542 4/20 0.54
▸ PDE2A O00408 1/20 0.51
▸ PDE3B Q13370 1/20 0.51
▸ PDE3A Q14432 1/20 0.51
▸ P2RY12 Q9H244 1/20 0.51
▸ XDH P47989 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL378879 0.77 ADORA2B (1.00) ADORA2BADORA3ADORA2AMEN1KMT2A
SCHEMBL23607984 0.75 ADORA2B (0.71) ADORA2BADORA2AMEN1KMT2APDE3B
SCHEMBL348494 0.74 GUSB (0.73) MEN1KMT2A
SCHEMBL6796628 0.73 ADORA2B (0.64) ADORA2BADORA3ADORA2AMEN1KMT2A
SCHEMBL9837292 0.72 ADORA2B (0.46) ADORA2BADORA3ADORA2AADORA1
SCHEMBL10723867 0.72 ADORA2B (1.00) ADORA2BADORA3ADORA2AADORA1
SCHEMBL7638825 0.71 ADORA2B (0.70) ADORA2BADORA3ADORA2AADORA1
SCHEMBL1051055 0.70 ADORA2B (0.60) ADORA2BMEN1KMT2AXDH
SCHEMBL5970362 0.70 ADORA2B (0.52) ADORA2BADORA3ADORA2AMEN1KMT2A
SCHEMBL5126528 0.70 MEN1 (0.55) ADORA2BADORA3ADORA2AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5453426-A Sulfur-containing xanthine derivatives as adenosine antagonists THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1995-09-26 — — US disclosed
WO-1990012797-A1 SULFER-CONTAINING XANTHINE DERIVATIVES AS ADENOSIN ANTAGONISTS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, U.S. DEPARTMENT OF COMMERCE (US) 1990-11-01 — — WO disclosed
Send feedback